Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Fall;2(4):222-7.

Vaccine-based immunotherapy for prostate cancer

S F Shariat, F Sadeghi, K M Slawin

Vaccine-based immunotherapy for prostate cancer

S F Shariat et al. Rev Urol. 2000 Fall.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • The Cellular and Molecular Immunotherapy in Prostate Cancer.
    Mukherjee AG, Wanjari UR, Prabakaran DS, Ganesan R, Renu K, Dey A, Vellingiri B, Kandasamy S, Ramesh T, Gopalakrishnan AV. Mukherjee AG, et al. Vaccines (Basel). 2022 Aug 22;10(8):1370. doi: 10.3390/vaccines10081370. Vaccines (Basel). 2022. PMID: 36016257 Free PMC article. Review.
  • Trial Watch: Toll-like receptor agonists in cancer immunotherapy.
    Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Smith M, et al. Oncoimmunology. 2018 Oct 11;7(12):e1526250. doi: 10.1080/2162402X.2018.1526250. eCollection 2018. Oncoimmunology. 2018. PMID: 30524908 Free PMC article. Review.

References

    1. Slovin SF, Scher HI. Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man-clinical trials at Memorial Sloan-Kettering Cancer Center. Semin Oncol. 1999;26:448–454. - PubMed
    1. Simons JW, Jaffee EM, Weber CE, et al. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res. 1997;57:1537–1546. - PMC - PubMed
    1. Tjoa B, Boynton A, Kenny G, et al. Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity. Prostate. 1996;28:65–69. - PubMed
    1. Tjoa B, Erickson S, Barren R, III, et al. In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy. Prostate. 1995;27:63–69. - PubMed
    1. Tjoa BA, Erickson SJ, Bowes VA, et al. Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate. 1997;32:272–278. - PubMed

LinkOut - more resources